Epidemic hemorrhagic fever(Hemorrhagic fever with renal syndrome)
Conditions
Interventions
Experimental group 1:Western medicine basic treatment combined with “Qingyi No. 1 granule”
Experimental group 2:Western medicine basic treatment combined with “Qingyi No. 2 granule”
Sponsors
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Comply with the diagnostic criteria for epidemic hemorrhagic fever. (2) Patients with epidemic hemorrhagic fever in the fifth stage of fever period, body temperature = 38 ° C, and the time of fever should be <=72 h; (3) Comply with the diagnostic criteria of TCM syndrome (both Wei and Qi Phases); (4) Aged 18 to 70 years old; (5) History of allergic reactions without related drugs. (6) Under the premise of fully understanding the study, voluntarily accept the treatment and detection of the treatment plan of this study, and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with abnormal liver function (AST, ALT exceeds the upper limit of normal by 5 times or more); (2) Patients with chronic kidney disease; (3) Combined with serious primary diseases such as cardiovascular and hematopoietic diseases, hematopoietic system, digestive ulcer disease, or serious diseases (such as tumors) that affect their survival; (4) Those who are allergic to drugs in the Chinese herbal compound; (5) Pregnant or lactating women; (6) Mentally or legally disabled patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Early intervention to reduce the incidence of critical illness (shock/kidney failure); | — |
Secondary
| Measure | Time frame |
|---|---|
| Antipyretic onset time and complete antipyretic time; | — |
Countries
China
Contacts
Public ContactZheng Peiyong
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed